These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24483185)

  • 1. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
    Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
    BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort.
    Nakanjako D; Ssewanyana I; Nabatanzi R; Kiragga A; Kamya MR; Cao H; Mayanja-Kizza H
    BMC Immunol; 2013 Jun; 14():26. PubMed ID: 23786370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56
    Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
    J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort.
    Nabatanzi R; Bayigga L; Cose S; Rowland-Jones S; Canderan G; Joloba M; Nakanjako D
    Clin Immunol; 2019 Apr; 201():55-60. PubMed ID: 30817998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abnormal distribution of NK cell subsets before HAART treatment may be related to the level of immune reconstitution in HIV patient.
    Sun S; Kong W; Cui X; Lin Y; Lu B; Pan Y; Huang J; Hu X
    Int Immunopharmacol; 2021 Jul; 96():107784. PubMed ID: 34162148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.
    Mantegani P; Tambussi G; Galli L; Din CT; Lazzarin A; Fortis C
    Immunology; 2010 Feb; 129(2):220-33. PubMed ID: 19824914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of inhibitory and activating NK cell receptor expression on NK cells in HIV-infected Chinese.
    Jiang Y; He L; Chen H; Bice T; Zhang Z; Liu J; Ding H; Han X; Shang H
    Cell Immunol; 2011; 271(2):219-26. PubMed ID: 21813117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
    Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
    Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells of HIV-1-infected patients with poor CD4
    Giuliani E; Vassena L; Di Cesare S; Malagnino V; Desimio MG; Andreoni M; Barnaba V; Doria M
    Immunol Lett; 2017 Oct; 190():185-193. PubMed ID: 28826739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response.
    Frias M; Rivero-Juarez A; Gordon A; Camacho A; Cantisan S; Cuenca-Lopez F; Torre-Cisneros J; Peña J; Rivero A
    PLoS One; 2015; 10(3):e0121019. PubMed ID: 25811634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
    Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Dysfunctions of CD56
    Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
    Front Immunol; 2021; 12():811091. PubMed ID: 35069597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome.
    Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L
    Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective downregulation of natural killer activating receptors on NK cells and upregulation of PD-1 expression on T cells in children with severe and/or recurrent Herpes simplex virus infections.
    Lenart M; Kluczewska A; Szaflarska A; Rutkowska-Zapała M; Wąsik M; Ziemiańska-Pięta A; Kobylarz K; Pituch-Noworolska A; Siedlar M
    Immunobiology; 2021 May; 226(3):152097. PubMed ID: 34015527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
    Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
    Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
    PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.